Acalabrutinib - CaLiGraph

CaLiGraph

Property	Value
rdf:type	Alkyne derivative Antineoplastic drug owl:NamedIndividual Human protein Orphan drug AstraZeneca brand Tyrosine kinase inhibitor Drug granted breakthrough therapy designation
rdfs:label	Acalabrutinib
owl:sameAs	dbr:Acalabrutinib
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Category:Alkyne_derivatives http://en.wikipedia.org/wiki/Category:Orphan_drugs http://en.wikipedia.org/wiki/Category:Antineoplastic_drugs http://en.wikipedia.org/wiki/Category:Human_proteins http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation http://en.wikipedia.org/wiki/Category:Tyrosine_kinase_inhibitors http://en.wikipedia.org/wiki/Category:AstraZeneca_brands http://en.wikipedia.org/wiki/Bruton's_tyrosine_kinase
skos:prefLabel	Acalabrutinib
skos:altLabel	acalabrutinib
clgo:alternativeName	Calquence
clgo:casNumber	1420477-60-6
clgo:chEBI	167707
clgo:chEMBL	3707348
clgo:drugbank	DB11703
clgo:fdaUniiCode	I42748ELQW
clgo:kegg	D10893
clgo:medlinePlus	a618004
clgo:pubchem	71226662

About: clgr:Acalabrutinib